Načítá se...
Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation
In favor of their outgrowth, cancer cells must resist immune surveillance and edit the immune response. Cancer immunoediting is characterized by fundamental changes in the cellular composition and the inflammatory cytokine profiles in the microenvironment of the primary tumor and metastatic niches,...
Uloženo v:
| Vydáno v: | Cell Commun Signal |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5244547/ https://ncbi.nlm.nih.gov/pubmed/28100240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-016-0155-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|